Fujifilm Diosynth Biotechnologies Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,272

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 4

  • Investments
  • 3

Fujifilm Diosynth Biotechnologies General Information

Description

Manufacturer of pharmaceutical products intended to combine technical leadership in cell culture, biologics, microbial fermentation, and cell and gene therapy with cGMP manufacturing facilities to advance tomorrow's medicines. The company specializes in offering complete solutions in pharmaceutical manufacturing from pre-clinical investigations and process development to commercial cGMP production, thereby helping clients to accelerate their progress, expand capabilities, streamline processes and strengthen innovation.

Contact Information

Website
www.fujifilmdiosynth.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Parent Company
FujiFilm
Primary Office
  • 3939 Biomedical Way
  • College Station, TX 77845
  • United States
+1 (979) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fujifilm Diosynth Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fujifilm Diosynth Biotechnologies‘s full profile, request access.

Request a free trial

Fujifilm Diosynth Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended to combine technical leadership in cell culture, biologics, microbial f
Pharmaceuticals
College Station, TX
4,272 As of 2023
0000000000

000000

si ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000000
Kuopio, Finland
000 As of 0000

00000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
0000000000000
Basel, Switzerland
00000 As of 0000
00000
0.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fujifilm Diosynth Biotechnologies Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FinVector Corporation Kuopio, Finland 000
00000 00000 Corporation Basel, Switzerland 00000 00000 00000000000 00000
00000000 Formerly VC-backed Cleveland, OH 00 000.00 00000000 000.00
000000000 000-0000 Corporate Backed or Acquired San Diego, CA 000000&0
00000000 Formerly VC-backed Germantown, MD 000 00000 000000000 00000
You’re viewing 5 of 30 competitors. Get the full list »

Fujifilm Diosynth Biotechnologies Patents

  • 341

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 198

    Granted

  • 49

    Pending

  • 000

    Expiring in next 12 mo

Fujifilm Diosynth Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230360228-A1 Systems and methods for producing a flipbook Pending 12-May-2023 00000000
US-20230078230-A1 Methods for the production of committed cardiac progenitor cells Pending 13-Sep-2021 0000000000
US-20220389436-A1 Methods to prevent rapid silencing of genes in pluripotent stem cells Pending 26-May-2021 000000000
AU-2022280051-A1 Methods to prevent rapid silencing of genes in pluripotent stem cells Pending 26-May-2021
CA-3217672-A1 Methods and compositions for ipsc-derived microglia Pending 05-May-2021
To view Fujifilm Diosynth Biotechnologies’s complete patent history, request access »

Fujifilm Diosynth Biotechnologies Executive Team (11)

Name Title Board Seat Contact Info
Lars Petersen Chief Executive Officer & President
Michael Lyons Chief Financial Officer
Christine Vannais Chief Operating Officer, RTP, North Carolina Site
Patricia Colombo Chief Compliance Officer
Ravi Narasimhan Chief Information Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Fujifilm Diosynth Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fujifilm Diosynth Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fujifilm Diosynth Biotechnologies‘s full profile, request access.

Request a free trial

Fujifilm Diosynth Biotechnologies Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Atara Biotherapeutics (T-Cell Operations and Manufacturing Facility in Thousand Oaks, California) 04-Apr-2022 000000000 00000 Buildings and Property 000000 00
Biogen (Denmark Manufacturing Facility) 01-Aug-2019 0000000000 00000 Pharmaceuticals 00000 000
TeraMedica 13-May-2015 Merger/Acquisition Other Healthcare Technology Systems
To view Fujifilm Diosynth Biotechnologies’s complete investments and acquisitions history, request access »